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Background-—Exercise testing with echocardiography or myocardial perfusion imaging is widely used to risk-stratify patients with
suspected coronary artery disease. However, reports of diagnostic performance rarely adjust for referral bias, and this practice may
adversely influence patient care. Therefore, we evaluated the potential impact of referral bias on diagnostic effectiveness and
clinical decision-making.
Methods and Results-—Searching PubMed and EMBASE (1990–2012), 2 investigators independently evaluated eligibility and
abstracted data on study characteristics and referral patterns. Diagnostic performance reported in 4 previously publishedmeta-analyses
of exercise echocardiography andmyocardial perfusion imagingwas adjusted using pooled referral rates and Bayesianmethods. Twenty-
one studies reported referral patterns in 49 006 patients (mean age 60.7 years, 39.6% women, and 0.8% prior history of myocardial
infarction). Catheterization referral rates after normal and abnormal exercise tests were 4.0% (95% CI, 2.9% to 5.0%) and 42.5% (36.2% to
48.9%), respectively, with odds ratio for referral after an abnormal test of 14.6 (10.7 to 19.9). After adjustment for referral, exercise
echocardiography sensitivity fell from 84% (80% to 89%) to 34% (27% to 41%), and specificity rose from 77% (69% to 86%) to 99% (99% to
100%). Similarly, exercise myocardial perfusion imaging sensitivity fell from 85% (81% to 88%) to 38% (31% to 44%), and specificity rose
from 69% (61% to 78%) to 99% (99% to 100%). Summary receiver operating curve analysis demonstrated only modest changes in overall
discriminatory power but adjusting for referral increased positive-predictive value and reduced negative-predictive value.
Conclusions-—Exercise echocardiography and myocardial perfusion imaging are considerably less sensitive and more specific for
coronary artery disease after adjustment for referral. Given these findings, future work should assess the comparative ability of
these and other tests to rule-in versus rule-out coronary artery disease. ( J Am Heart Assoc. 2013;2:e000505 doi: 10.1161/
JAHA.113.000505)
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E xercise testing with radionuclide imaging or echocardi-ography is widely used to evaluate patients with
suspected cardiovascular disease, and >12 million studies
are performed annually in the United States.1,2 The American
College of Cardiology/American Heart Association practice
guidelines for exercise testing recommend that physicians
interpret stress test results in the context of a patient’s
pretest risk, using posttest disease probability as well as test
performance characteristics to guide clinical decision-mak-
ing.3 However, an important limitation of this approach is that
reports of stress test diagnostic performance may be
influenced by referral bias4–6—sometimes called “verification
bias” or “workup bias”—and studies do not routinely adjust
for this phenomenon.7–10 Referral bias occurs when patients
with an abnormal stress test result are referred to cardiac
catheterization at a higher rate than are patients with normal
stress test results. While clinically appropriate, failing to
adjust for this difference in referral rates when measuring test
performance can significantly distort the observed diagnostic
characteristics of exercise testing. This is because patients
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referred for cardiac catheterization, the gold standard, may
have a higher likelihood of disease than those who are
not.11,12 An exception is the work by Gibbons and colleagues,
in which a posttest referral bias correction was applied, with
adjustment of sensitivity and specificity.3,11
The clinical implications of referral bias for patient manage-
ment and decision making have received little prior attention
but may be substantial. However, for reasons that are unclear,
referral bias is almost universally unaccounted for in studies of
exercise testing.7–10 We hypothesize that this may be because
prior studies of referral bias enrolled populations from single
centers,5,11–14 thus limiting their impact due to concerns about
generalizability. To address this issue, we systematically
reviewed the literature on referral rates after exercise echo-
cardiogram (ECHO) or myocardial perfusion imaging (MPI) and
used these rates to adjust measures of exercise test perfor-
mance. We also examined the potential impact of referral bias
on posttest disease risk and clinical decision making.
Methods
Search Strategy
We searched PubMed and EMBASE from January 1990 to
November 2012 for English-language articles reporting cardiac
catheterization referral rates after normal or abnormal exer-
cise MPI and ECHO. Our search terms were developed with a
clinical and graduate medical education librarian (D.V.) and
included the Medical Subject Headings (MeSH) coronary
disease, exercise test, myocardial perfusion imaging, single
photon emission computed tomography, echocardiography, and
humans; keywords identifying exercise tests, including stress
test, thallium, sestamibi, and technetium; and keywords
identifying referral, including refer and referr* (for “referral”
and variants), verif* (for “verification” and variants), and select,
selected, and selecti* (for “selection” and variants). We also
searched the reference list of meta-analyses of exercise test
performance and identified additional publications through
discussion between collaborators. Our report adheres to
guidelines for systematic reviews published by the Meta-
analysis of Observational Studies in Epidemiology (MOOSE)
group (see Appendix S1 for details).
Study Selection
Two investigators (J.L. and S.B.), working independently, in
duplicate, reviewed all abstracts and identified studies that
indicated or suggested that the authors reported referral rates
after exercise testing. Studies then underwent full text data
extraction if (1) exercise ECHO or exercise MPI was performed
to detect or evaluate coronary artery disease (CAD) and (2)
referral rates to cardiac catheterization were reported and
stratified by stress test result (eg, normal, abnormal). Studies
were excluded if they enrolled only patients with a history of
myocardial infarction (MI), percutaneous transluminal coro-
nary angioplasty (PTCA), or coronary artery bypass grafting
(CABG); they enrolled patients with unstable coronary
syndromes; or the majority of patients underwent pharmaco-
logical stress testing. Studies enrolling patients with a history
of MI or revascularization were included if these patients
comprised <15% of the study population. This threshold was
considered reasonable because it was comparable to or lower
than the prevalence of MI in our reference meta-analysis
studies9,15 and another systematic review of stress MPI.7
Data Extraction
The same 2 investigators performed data extraction indepen-
dently, in duplicate, using a standardized protocol and
reporting form. Study characteristics recorded included (1)
identifying information (first author, journal, country, institu-
tion, publication year), (2) patient characteristics (mean age,
percentage of male patients, percentage of patients with
previous MI, PTCA, or CABG), (3) stress test characteristics
(test used, type of exercise, positivity criterion, how authors
defined significant coronary artery disease, eg, ≥50% stenosis
or ≥70% stenosis), (4) referral patterns (number of patients
with normal or abnormal stress test results and number of
patients subsequently undergoing cardiac catheterization),
and (5) diagnostic yield (number of true positives, false
positives, true negatives, and false negatives). Disagreements
between reviewers during the abstract screening and data
extraction process were resolved through discussion.
Data Analysis
Boththeproportionofpatientsreferredforcardiaccatheterization
and the odds ratio for cardiac catheterization referral after a
normal or abnormal stress test result were derived for each
study, and 95% CIs were calculated. These estimates were
pooled using the Mantel–Haenszel fixed-effects model,
weighted with inverse variance, and the DerSimonian–Laird
random-effects model.16 We assessed the between-study
heterogeneity using the Cochran Q statistic and study consis-
tency using the I2 statistic, which quantifies the proportion of
heterogeneity that is not due to chance. If the P-value for the Q
statistic was <0.10 or the I2 statistic exceeded 50%, a random-
effects model was reported instead of a fixed-effects model.
Potential sources of heterogeneity also were explored. A 2-
tailed P-value of <0.05 was judged as statistically significant.
Because referral rates were generally not the primary outcome
in any of the included studies, the possibility of publication bias
was not explored. We used the METAN command of Stata
(version 12, StataCorp) to perform all meta-analyses.
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Adjusting Diagnostic Test Performance for
Referral
As a reference standard for exercise test performance, we
compiled studies of exercise ECHO and MPI from 4 sources:
the most widely cited meta-analysis of stress test perfor-
mance (Fleischmann et al),15,17 a recent meta-analysis
(Heijenbrok-Kal et al),9 and 2 peer-reviewed meta-analyses
from the Ontario Health Technology Assessment Series.18,19
Henceforth, these 4 studies will be referred to collectively as
our exercise test meta-analysis studies. They contributed a
total of 45 unique studies of exercise ECHO (15 studies) or
MPI performance (30 studies) (see Appendix S1).
We then used Bayesian methods developed by Begg and
Greenes to adjust exercise test performance reported in each
of these 45 studies for referral bias.4 Their method assumes
that referral to the gold standard test (cardiac catheterization)
and disease status (the presence or absence of CAD) are
conditionally independent given the exercise test result. This
assumption is generally considered reasonable since the
decision to perform cardiac catheterization can only be
influenced by “visible” factors, such as the exercise test result
and other clinical characteristics.20 Diagnostic test perfor-
mance with and without adjustment for the referral process
can then be derived with the equation:
PrðT jDÞ
PrðT jDÞ ¼
PrðT jD; RþÞPrðR þ jTÞ
PrðT jD; RþÞPrðR þ jTÞ
where R is referral, which is synonymous here with cardiac
catheterization; T is exercise test result or its complement (T ),
equivalent to a normal or abnormal result; D is disease status;
Pr(T|D) is the sensitivity (when T is abnormal and D is disease
presence) of the exercise test, accounting for the referral
process; and Pr(T|D, R+) is the sensitivity of the exercise test,
as determined in the cohort undergoing cardiac catheteriza-
tion (not accounting for the referral process). An analogous
equation can be derived for specificity by reversing disease
status and test result.
Estimates of exercise test sensitivity and specificity in
cohorts undergoing cardiac catheterization were derived
directly from our 45 exercise test meta-analysis studies,
and we adjusted these values with pooled estimates of
referral rates from our literature search. To ensure we applied
referral corrections appropriately, we rated each relevant
study in our exercise test meta-analyses by its likelihood of
referral bias. Fleischmann et al15 also categorized studies by
their likelihood of referral bias, and we limited our analyses to
studies for which referral bias was rated as “likely” or
“certain.” We then used a random-effects model to reestimate
diagnostic performance for exercise ECHO and MPI after
correction for referral bias. After performing a logit transfor-
mation, we used a Taylor series expansion and the delta
method to construct 95% CIs.21 The overall methodological
approach is summarized in Figure 1.
Summary Performance of Each Test
To evaluate the impact of referral bias on the overall
diagnostic performance of exercise MPI and ECHO, we
performed summary receiver operating characteristic (ROC)
curve analysis.22 ROC curves illustrate the trade-off between
sensitivity and specificity as the threshold for defining a
diagnostic test result as abnormal is varied, and they adjust
for the possibility that different studies may use different test
thresholds.23 To perform our analysis, we logistically trans-
formed the true-positive rate (TPR; sensitivity) and false-
positive rate (FPR, 1specificity) and fit a linear regression
model, with the log-odds ratio (OR; log-odds TPRlog-odds
FPR) as the dependent variable and the test threshold
(log-odds TPR+log-odds FPR) as the independent variable.22
The regression model included an indicator variable for
referral bias correction, and its b-coefficient gives a measure
of the difference in diagnostic performance after adjusting for
referral. Positive coefficients indicate improved discriminatory
power and negative coefficients correspond to a reduction in
discriminatory power. The model’s dependent variable is
invariant to the referral process.20
Clinical Implications and Predictive Value of
Diagnostic Testing
To estimate the impact of referral bias correction on posttest
risk stratification and clinical decision-making, we calculated
positive predictive value and negative predictive value over a
Figure 1. Flow diagram of selection process for studies included in meta-analysis.
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range of pretest probabilities for CAD. We used the odds-
likelihood ratio version of Bayes’ theorem: posttest odds=pre-
test odds9likelihood ratio; where the positive likelihood ratio
(LR) is sensitivity/(1specificity) and the negative LR is
(1sensitivity)/specificity. The delta method was used to
estimate 95% CIs as previously described.
Overall Methodological Approach
In summary, we searched PubMed and EMBASE for articles
reporting cardiac catheterization referral rates after normal or
abnormal exercise MPI and ECHO. From studies that met
inclusion criteria, we extracted data on referral rates to
cardiac catheterization stratified by stress test result, along
with other patient and study characteristics, and pooled these
referral rates. We then identified 45 studies of exercise ECHO
and MPI from previously published meta-analyses, and we
used Bayesian methods to adjust exercise test performance
reported in each of these 45 studies for referral bias using our
pooled referral rates. We also performed summary ROC curve
analysis to evaluate the impact of referral bias on the overall
diagnostic performance of exercise MPI and ECHO. Finally, to
estimate the impact of referral bias correction on posttest risk
stratification and clinical decision making, we calculated
positive predictive value and negative predictive value over a
range of pretest probabilities for CAD.
Results
Literature Search
Our literature search yielded a total of 819 citations, of which
107 were selected as being potentially relevant and obtained
for further screening (Figure 2). Of these 107 studies, 17
reported referral patterns after normal or abnormal exercise
tests and were included in our analysis.11,12,14,24–41 The
characteristics of these studies and their 49 006 participants
are shown in Table 1. The mean age was 60.7 years, 39.6%
were women, 0.8% had a prior history of myocardial infarction
(reported in 13 studies), and 0.1% had a prior history of
revascularization (reported in 14 studies). In 13 studies, the
form of exercise used was treadmill testing, and 3 studies
Figure 2. Overview of methodological approach.
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used a bicycle; 1 study did not report the mode of exercise.
Significant CAD was present in 18% to 100% of patients
undergoing cardiac catheterization (reported in 13 studies).
Overall, the studies were heterogeneous with respect to the
population prevalence of prior coronary disease and the
indications for testing and referral.
Cardiac Catheterization Referral Rates
Cardiac catheterization referral rates after normal and abnor-
mal stress tests results from our literature review are shown
in Figures 3 and 4. Because only a few studies reported
referral patterns after exercise ECHO, and because we did not
believe that referral patterns would differ in a clinically
meaningful way between exercise ECHO and MPI, we
combined all studies together. Using a random-effects model,
the pooled referral rate after a normal test result was 4.0%
(95% CI, 2.9% to 5.0%), and that after an abnormal test result
was 42.5% (95% CI, 36.2% to 48.9%). The pooled odds ratio for
referral after an abnormal test, compared with a normal test,
was 14.6 (95% CI, 10.7 to 19.9).
Diagnostic Effectiveness After Adjustment for
Referral Bias
Using Bayesian methods, we adjusted the diagnostic perfor-
mance reported in each of our 45 exercise test meta-analysis
studies. The pooled sensitivity of exercise ECHO and MPI fell
from 84% (95% CI, 80% to 89%) and 85% (95% CI, 81% to 88%)
prior to adjusting for the referral process to 34% (95% CI, 27%
to 41%) and 38% (95% CI, 31% to 44%) after adjustment,
respectively (Table 2). The pooled specificity of exercise



















Jang et al35 1287 53.2 58 0 NA Treadmill <30 61
Roger et al12 Male only 1965 60 100 0 0 Treadmill 6 80
Female
only
1714 60 0 0 0 Treadmill 6 60
Vlachopoulos et al32 50 59 100 0 0 Treadmill NA NA
Wennike et al31 200 62 46 NA NA Treadmill NA 100
MPI
Cecil et al14 2688 NA NA 0 0 Treadmill <90 42
Charvat et al39 126 59.9 60 0 NA Bicycle NA 56
Diamond et al38 9171 NA NA NA NA Treadmill <180 29
Hachamovitch et al37 1021 69 55 0 0 Treadmill <60 NA
Hannoush et al36 334 56 80 14 NA Treadmill <90 80
Hosie et al24 80 50 55 NA NA Bicycle NA 63
Kane et al34 6801 61 55.4 NA 0 Treadmill <90 60
Koistinen et al25 136 47.6 62 0 0 Bicycle NA 44
Lauer et al26 Male only 2351 58 100 7 0 Treadmill <90 NA
Female
only
1318 59 0 3 0 Treadmill <90 NA
Miller et al11 14 273 62 59 0 0 Treadmill <90 72
Nallamothu et al27 2700 59 56 0 0 NA <180 NA
Roeters van Lennep
et al33
Male only 322 59.4 100 0 0 Treadmill <90 86
Female
only
294 59.1 0 0 0 Treadmill <90 65
Schwartz et al28 2175 NA 100 0 0 Treadmill NA 18
CAD indicates coronary artery disease; cath, cardiac catheterization; ECHO, echocardiography; MI, myocardial infarction; MPI, myocardial perfusion imaging; NA, not available from article.
*Jang et al,35 Charvat et al,39 and Hannoush et al36 reported prior coronary artery bypass graft surgery only and did not report prior percutaneous coronary intervention.
†Diamond et al38 reported prevalence only in patients with normal exercise test result.
‡Wennike et al,31 Charvat et al,39 Koistinen et al,25 and Roeters van Lennep et al33 reported prevalence only in patients with abnormal exercise test result.
DOI: 10.1161/JAHA.113.000505 Journal of the American Heart Association 5















ECHO and MPI rose from 77% (95% CI, 69% to 86%) and 69%
(95% CI, 61% to 78%) prior to adjusting for the referral process
to 99% (95% CI, 99% to 100%) and 99% (95% CI, 99% to 100%)
after adjustment, respectively.
Summary ROC Analysis
In a model comparing exercise ECHO without correction for
referral bias to exercise ECHO with correction for referral bias,
there was a trend toward a decrease in discriminatory power
(parameter estimate for reduction 1.8; 95% CI, 3.6 to 0.1).
No decrease in discriminatory powerwas found for exerciseMPI
(parameter estimate for reduction 0.2; 95% CI, 1.3 to 0.9).
Clinical Decision Making and Posttest Risk
Stratification
Figure 5 shows how the posttest risk of CAD varies by pretest
risk, with or without correction for referral bias. For both
exercise ECHO and MPI, adjusting for referral resulted in an
increase in the posttest risk of disease after either a normal or
abnormal test result. Posttest disease risk was comparatively
higher after a normal test result primarily because referral bias
adjustment significantly reduced sensitivity (thereby reducing
negative predictive value). Similarly, posttest disease risk was
comparatively higher after an abnormal test result primarily
because referral bias adjustment significantly increased spec-
ificity (thereby increasing positive predictive value). The value of
the test, in terms of guiding clinical decision making, was
therefore comparatively higher after an abnormal test result
than a normal test result. This is also demonstrated by the
distance between the adjusted curves in Figure 5 and the
45-degree line, as the latter represents no incremental information
from diagnostic testing (because pretest disease risk equals
posttest disease risk along this line). Appropriately, this distance is
greater after an abnormal test result than a normal test result.
Sensitivity Analyses
We evaluated the overall robustness of our results by
reanalyzing our data using the upper and lower CI bounds
for pooled referral rates after normal and abnormal tests,
NOTE: Weights are from random effects analysis
Overall  (I-squared = 96.3%, p = 0.000)
Roeters van Lennep et al, 1999
Diamond et al, 2008
Hannoush et al, 2003
Study
Hosie et al, 1993
Vlachopoulos et al, 2005
Nallamothu et al, 1995
Roger et al, 1997
Cecil et al, 1996
Miller et al, 2002
Lauer et al, 1996
Hachamovitch et al, 2004
Kane et al, 2008
Roeters van Lennep et al, 1999
Roger et al, 1997
Schwartz et al, 1993
Wennike et al, 2010
Charvat et al, 2004
Jang et al, 2011




































































Figure 3. Cardiac catheterization referral rates after normal exercise ECHO or MPI results. Note: Lower 95% confidence intervals for some
studies intersect zero. Area of each square corresponds to weight of the study in meta-analysis. CI indicates confidence interval; ECHO,
echocardiography; MPI, myocardial perfusion imaging.
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respectively. Selecting these values would be expected to
attenuate the impact of referral bias by minimizing the relative
difference in referral rates. In this analysis, the sensitivity of
exercise ECHO and MPI fell to 44% (95% CI, 35% to 52%) and
48% (95% CI, 40% to 56%) and the specificity rose to 99% (95%
CI, 98% to 100%) and 98% (95% CI, 97% to 98%), respectively.
We also excluded all studies of referral in which any
participants were reported as having a history of MI or
revascularization.26,36 In this analysis, the referral rates after
normal and abnormal exercise tests were 4.1% (95% CI, 2.8%
to 5.3%) and 43.7% (36.5% to 50.9%), respectively, with odds
ratio for referral after an abnormal test of 14.3 (9.8 to 20.7).
After adjusting for referral, the sensitivity of exercise ECHO
and MPI fell to 34% (95% CI, 26% to 41%) and 38% (95% CI,
31% to 44%) and the specificity rose to 99% (95% CI, 99% to
100%) and 99% (95% CI, 99% to 100%), respectively.
Discussion
By systematically reviewing cardiac catheterization referral
rates and aggregating them to adjust pooled estimates of
exercise test performance, we found that adjusting for referral
NOTE: Weights are from random effects analysis
Overall  (I-squared = 98.2%, p = 0.000)
Study
Nallamothu et al, 1995
Kane et al, 2008
Charvat et al, 2004
Vlachopoulos et al, 2005
Wennike et al, 2010
Schwartz et al, 1993
Lauer et al, 1996
Hachamovitch et al, 2004
Roger et al, 1997
Miller et al, 2002
Roger et al, 1997
Koistinen et al, 1990
Jang et al, 2011
Roeters van Lennep et al, 1999
Hosie et al, 1993
Roeters van Lennep et al, 1999
Hannoush et al, 2003
Lauer et al, 1996





































































Figure 4. Cardiac catheterization referral rates after abnormal exercise ECHO or MPI results. CI indicates confidence interval; ECHO,
echocardiography; MPI, myocardial perfusion imaging; No., number.
Table 2. Diagnostic Effectiveness of Exercise ECHO and MPI With and Without Adjustment for Referral
ECHO MPI
Sensitivity, % (95% CI) Specificity, % (95% CI) Sensitivity, % (95% CI) Specificity, % (95% CI)
Unadjusted* 84 (80 to 89) 77 (69 to 86) 85 (81 to 88) 69 (61 to 78)
Adjusted† 34 (27 to 41) 99 (99 to 100) 38 (31 to 44) 99 (99 to 100)
ECHO indicates echocardiography; MPI, myocardial perfusion imaging.
*Diagnostic effectiveness based on random-effects meta-analysis of sensitivity and specificity reported in 15 studies of exercise ECHO and 30 studies of exercise MPI (45 studies in total).
†Adjusted for referral rates to cardiac catheterization after abnormal or normal exercise test result.
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(which was 15-fold higher after an abnormal result) signifi-
cantly reduced test sensitivity and increased test specificity.
While these adjustments only modestly reduced overall
discriminatory power, a patient’s estimated posttest disease
risk shifted considerably, substantially affecting utility. To our
knowledge, this analysis is the first meta-analysis to system-
atically apply actual cardiac catheterization referral rates after
stress testing to fully understand the clinical implications of
referral bias.
Our findings have important implications for clinical
decision making. A recent study of Medicare patients
reported that stress tests using radionuclide imaging or
echocardiography account for 80% of all stress test studies
performed,42 and the volume of these procedures has grown
markedly over the past 2 decades.43 Most importantly for
clinical care, we found that the sensitivity of exercise testing
is much lower than previously reported. Wider recognition of
this among clinicians—particularly primary care physicians
and hospitalists—may influence how health care profession-
als use exercise ECHO and MPI to rule-in versus rule-out
disease, since test specificity substantially exceeds
sensitivity.
Further research is needed to understand the implications
of these findings for the practicing clinician.44 We describe 2
possible clinical scenarios that follow from our findings: A
























































































Difference (Adjusted - Unadjusted)
Figure 5. Posttest disease risk after normal or abnormal exercise ECHO or MPI, with and without adjustment for referral process. Note: Error
bars correspond to 95% CI. ECHO indicates echocardiography; MPI, myocardial perfusion imaging.
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CAD is considered for stress testing in an evaluation for
physiologically significant CAD. If a physician preferentially
aims to rule-out CAD in this patient, given the impact of
referral bias on the diagnostic accuracy of stress imaging,
alternative noninvasive technologies with higher sensitivity,
such as coronary computed tomography angiography or other
novel technologies,45 may be more appropriate tests to use
first. Another scenario is that a patient with an intermediate
likelihood of CAD is similarly considered for stress testing in
an evaluation for physiologically significant CAD. If a physician
preferentially aims to rule-in CAD in this patient, stress
imaging may be considered as the more appropriate test to
use first because it is highly specific after accounting for the
referral process.
We recently published the results of a multicenter, blinded
trial that enrolled 537 patients with suspected CAD who were
referred for stress MPI and underwent a blood-based GES.46
To attenuate the impact of referral bias, we attempted to
determine coronary anatomy in all patients using cardiac
catheterization, when clinically appropriate, or coronary
computed tomography angiography. Approximately 83% of
eligible patients underwent at least 1 of these 2 tests, and
site-read and core-lab MPI sensitivity was 27% and 36%;
specificity was 92% and 90%, respectively. Though coronary
computed tomography angiography is an imperfect substitute
for cardiac catheterization, these results support our findings
about the impact of referral bias.
Though we report significantly lower sensitivity and higher
specificity than prior meta-analyses of stress testing, the
prognostic value of exercise ECHO or MPI—in terms of
adverse cardiovascular events—is also cited as a component
of its diagnostic utility. However, while the prognostic value of
a negative stress test is favorable,47 a recent study suggests
that this may be partly driven by enrollment of patients at
lower risk for CAD.48 In a study of 39 515 patients
undergoing stress-rest MPI between 1991 and 2009, Rozan-
ski and colleagues reported a significant progressive decline
in the prevalence of abnormal (from 40.9% in 1991 to 8.7% in
2009) and ischemic (from 29.6% in 1991 to 5.0% in 2009)
studies. These authors concluded that more cost-effective
strategies for evaluating low-risk patients are needed.
Our study has several important limitations. Our adjusted
values of corrected sensitivity and specificity are analytic
estimates only,49 the study populations were heterogeneous
with respect to important clinical characteristics, and the
validity of our results depends on how accurately referral
rates from the literature review reflect those of patients
comprising our exercise test meta-analysis studies. While
several studies reported fairly similar referral rates, it is
important to note that referral practices vary by site and
provider. In addition, the diagnostic performance of exercise
ECHO and MPI also varies by site, and physicians interpreting
these studies may operate at different points on the ROC
curve. Results obtained in nonacademic settings may also
differ. Our summary ROC curve analysis partially accounted
for these possibilities by evaluating overall diagnostic perfor-
mance.
Another limitation is that our analysis also did not account
for other important clinical characteristics that may affect
diagnostic test performance and clinical decision making,
including clinical factors such as patient-level risk and disease
severity and nonclinical factors such as patient preferences
and liability concerns. For example, patients with abnormal
test results who are referred to cardiac catheterization may
have more severe symptoms or a greater risk burden than
patients with similar test results who are not referred. This
practice would tend to attenuate the impact of referral bias on
diagnostic test performance. Furthermore, the Fleischmann
et al meta-analysis may not be reflective of contemporary
practice, and some authors disagree with its findings.
Similarly, the Ontario Health Technology Assessment series
is not a widely recognized reference.
An additional limitation of our work is that cardiac
catheterization is a poor gold standard for exercise testing.
Recent studies have examined the importance of functional
characteristics of the coronary arteries and microcirculation,
rather than just coronary anatomy, and our understanding of
these phenomena is growing.50,51 However, a more accurate
understanding of diagnostic performance may further improve
risk factor modification in this cohort.
Conclusions
Based on pooled results from several studies and clinical
sites, exercise ECHO and MPI are less sensitive and more
specific for coronary artery disease after adjusting for the
referral process. Accounting for this adjustment may influ-
ence how clinicians use these tests to rule-in versus rule-out
disease, and more sensitive noninvasive methods for diag-
nosing coronary artery disease may improve patient care.
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